 |
|
|
|
 |
| AUGUST 6 ,
2009 | ISSUE NUMBER 110 VOL 6 |
Warnings
FDA Strengthens TNF Blocker Labels
TNF Blockers, such as Remicade, Enbrel, and Humira will now contain warnings for lymphoma in children. That’s on top of the cancer warnings already included on these top cancer meds.
Disclosure
Lilly Sales Force Buyouts Revealed
The drug giant announced a plan to offer buyouts to 4,000 sales representatives in an effort to trim its bloated sales force without resorting to layoffs.
Approval
Avastin Gets Green Light for Use in Kidney Cancer
Score another win for Genentech and its cancer treatment Avastin. On Monday, the biotech giant, now owned entirely by Roche, announced that FDA had approved the drug for kidney cancer.
Marketing
Video Games: Key to the Future of Healthcare?
Initial survey and results suggest that health games and virtual worlds bear the potential to be “game changers” by improving education, provoking greater engagement, and engendering positive behavior to enhance health and wellness.
|
 |
|  Palio launched Susurro, a new tool to monitor social media for clients’ brands that focuses on consumer or patient online discussions of brands and competitors // Merz Pharmaceuticals named Bill Edwards, vice president, general counsel and chief compliance officer; Mikael Svensson, vice president, medical and aesthetic services; and Dave Shoup, vice president, neurology // Carbon, part of CommonHealth, hired Patrick Jagodzinski as an account coordinator; promoted Jacquelyn Deubert and Vicki Fiarman to associate director, production; promoted Brian Drown and Jaclyn Ferguson to senior account coordinator // Kendle appointed Stephen Cutler to senior vice president and chief operating officer //
Laureate Pharma appointed Daniel E. Leone as vice president of business development // Caraco Pharmaceutical Laboratories made Jitendra N. Doshi interim CEO and director // Marinus Pharmaceuticals appointed George F. Horner III of Sofinnova Ventures and Harry T. Rein of Foundation Medical Partners to its board of directors // Altum promoted Darah Semancik to senior art director // AbelsonTaylor hired Courtney Mason as account planner and promoted Deika Abdi and Abby Adams to account executive //
|
 |
August 12 An Evolving Standard for Success: Proving Product Value Through Comparative Effectiveness Data
Wednesday, August 12, 2009 at 11AM EDT
|
|
August
11–22 3rd Annual Forum on Tracking State Laws and Aggregate Spend,
Arlington, VA
September
14–15 4th Annual Forum on Educational Grants for the Bio/Pharmaceutical Industry,
Philadelphia, PA
September
21–24 5th
Annual Process Excellence Week for the Service & Transactional
World, Chicago, IL
September
30 Prix Galien 2009 Awards Ceremony, New York, NY
October
5–7 BioNetwork
2009: The 7th Annual Pharmaceutical-Biotech Partnering
Conference, Laguna Niguel, California |
|
|
|
 |
|
 |
|
 |
| Should the Department of Justice end pharma’s tactic of paying off other firms to postpone generic competition? |
|
|
|
|
You are subscribed to Pharm Exec Direct..
To unsubscribe,
click here
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
